title: Sugammadex in a Patient with Brugada Syndrome.
abstract: Brugada Syndrome was first described in 1992 by Pedro Brugada as a genetic syndrome that is characterized by ventricular arrhythmias that may result in sudden cardiac arrest. In particular, a right bundle branch block and ST segment elevation in the right precordial leads are observed. Many perioperative pharmalogical and physiological factors can trigger malignant arrhythmias. Although it is a rare condition, the anaesthestic management of Brugada syndrome is important because of the potentially fatal complications. Many anaesthetics have been administered during the operation of patients with Brugada Syndrome. The use of sugammadex instead of the anaesthetic management of patients with Brugada syndrome is discussed in this study.
authors.affiliation: Department of Anaesthesiology and Reanimation, Çukurova University School of Medicine, Adana, Turkey.
authors.forename: Ebru
authors.initials: E
authors.lastname: Biricik
authors.affiliation: Department of Anaesthesiology and Reanimation, Çukurova University School of Medicine, Adana, Turkey.
authors.forename: Zehra
authors.initials: Z
authors.lastname: Hatipoğlu
authors.affiliation: Department of Anaesthesiology and Reanimation, Çukurova University School of Medicine, Adana, Turkey.
authors.forename: Çağatay
authors.initials: Ç
authors.lastname: Küçükbingöz
keywords: Brugada Syndrome; anaesthesia; sugammadex